Nadal-Wollbold Florence, Pawlowski Marc, Lévy-Toledano Sylviane, Berrou Eliane, Rosa Jean Philippe, Bryckaert Marijke
U348 INSERM, IFR 6 Circulation Lariboisière, Hôpital Lariboisière, 41 Bvd de la Chapelle, 75475 Cedex 10, Paris, France.
FEBS Lett. 2002 Nov 20;531(3):475-82. doi: 10.1016/s0014-5793(02)03587-1.
Extracellular signal-regulated kinase (ERK) activation pathways have been well characterized in a number of cell types but very few data are available for platelets. The thrombin-induced signaling pathway leading to ERK2 activation in platelets is largely uncharacterized. In this study, we investigated the kinases involved in thrombin-induced ERK2 activation in conditions of maximal ERK2 activation. We found that thrombin-induced mitogen-activated protein kinase/ERK kinase (MEK)1/2 activation was necessary for ERK2 phosphorylation. We obtained strong evidence that conventional protein kinase Cs (PKCs) and calcium are involved in thrombin-induced ERK2 activation. First, ERK2 and MEK1/2 phosphorylation was totally inhibited by low concentrations (1 microM) of RO318425, a specific inhibitor of conventional PKCs. Second, Ca(2+), from either intracellular pools or the extracellular medium, was necessary for ERK2 activation and conventional PKC activation, excluding the involvement of a new class of calcium-insensitive PKCs. Third, LY294002 and wortmannin had no significant effect on ERK2 activation, even at concentrations that inhibit phosphatidylinositol (PI)3-kinase (5 microM to 25 microM and 50 nM, respectively). This suggests that PI3-kinase was not necessary for ERK2 activation and therefore, that PI3-kinase-dependent atypical PKCs were not involved. Surprisingly, in contrast to proliferative cells, we found that the serine/threonine kinases Raf-1 and B-Raf were not an intermediate kinase between conventional PKCs and MEK1/2. After immunoprecipitation of Raf-1 and B-Raf, the basal glutathione S-transferase-MEK1 phosphorylation observed in resting platelets was not upregulated by thrombin and was still observed in the absence of anti-Raf-1 or anti-B-Raf antibodies. In these conditions, the in vitro cascade kinase assay did not detect any MEK activity. Thus in platelets, thrombin-induced ERK2 activation is activated by conventional PKCs independently of Raf-1 and B-Raf activation.
细胞外信号调节激酶(ERK)激活途径在多种细胞类型中已得到充分研究,但关于血小板的相关数据却非常少。凝血酶诱导血小板中ERK2激活的信号通路在很大程度上仍未明确。在本研究中,我们在ERK2最大激活的条件下,研究了参与凝血酶诱导ERK2激活的激酶。我们发现凝血酶诱导的丝裂原活化蛋白激酶/ERK激酶(MEK)1/2激活是ERK2磷酸化所必需的。我们获得了有力证据,表明传统蛋白激酶C(PKC)和钙参与了凝血酶诱导的ERK2激活。首先,低浓度(1微摩尔)的RO318425(一种传统PKC的特异性抑制剂)可完全抑制ERK2和MEK1/2的磷酸化。其次,细胞内池或细胞外培养基中的Ca2+对于ERK2激活和传统PKC激活都是必需的,排除了一类新的钙不敏感PKC的参与。第三,LY294002和渥曼青霉素即使在抑制磷脂酰肌醇(PI)3激酶的浓度(分别为5微摩尔至25微摩尔和50纳摩尔)下,对ERK2激活也没有显著影响。这表明PI3激酶对于ERK2激活不是必需的,因此PI3激酶依赖性非典型PKC也未参与。令人惊讶的是,与增殖细胞不同,我们发现丝氨酸/苏氨酸激酶Raf-1和B-Raf不是传统PKC和MEK1/2之间的中间激酶。在对Raf-1和B-Raf进行免疫沉淀后,静息血小板中观察到的基础谷胱甘肽S-转移酶-MEK1磷酸化并未被凝血酶上调,并且在没有抗Raf-1或抗B-Raf抗体的情况下仍可观察到。在这些条件下,体外级联激酶测定未检测到任何MEK活性。因此在血小板中,凝血酶诱导的ERK2激活是由传统PKC独立于Raf-1和B-Raf激活而激活的。